Cyclin-Dependent Kinase Modulators and Cancer Therapy

被引:0
|
作者
Marialucia Gallorini
Amelia Cataldi
Viviana di Giacomo
机构
[1] University G. d’Annunzio,Department of Pharmacy
[2] University G. d’Annunzio,undefined
[3] University G. d’Annunzio,undefined
关键词
Multiple Myeloma; Mantle Cell Lymphoma; Flavopiridol; Endometrial Adenocarcinoma; INK4 Family;
D O I
10.1007/BF03261895
中图分类号
学科分类号
摘要
The cell cycle of eukaryotic cells varies greatly from species to species and tissue to tissue. Since an erroneous control of the cell cycle can have disastrous consequences for cellular life, there are genetically programmed signals, so-called cell cycle checkpoints, which ensure that all events of each stage are completed before beginning the next phase. Among the numerous molecules involved in this process, the most important are the cyclin-dependent kinases (CDKs), proteins that are activated only when bound to cyclins (regulatory proteins with fluctuating concentrations).
引用
收藏
页码:377 / 391
页数:14
相关论文
共 50 条
  • [21] Cyclins, cyclin-dependent kinases, cyclin-dependent kinase inhibitors and their role in head and neck cancer
    Jeannon, JP
    Wilson, JA
    CLINICAL OTOLARYNGOLOGY, 1998, 23 (05): : 420 - 424
  • [22] Cyclin-dependent kinase inhibitor therapy for hematologic malignancies
    Bose, Prithviraj
    Simmons, Gary L.
    Grant, Steven
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (06) : 723 - 738
  • [23] Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy
    Li BinBin
    Wang Bo
    Zhu ChengMing
    Tang Di
    Pang Jun
    Zhao Jing
    Sun ChunHui
    Qiu MiaoJuan
    Qian ZhiRong
    慢性疾病与转化医学(英文), 2019, 5 (03) : 155 - 169
  • [24] Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy? Miniperspective
    Philip, Stephen
    Kumarasiri, Malika
    Teo, Theodosia
    Yu, Mingfeng
    Wang, Shudong
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (12) : 5073 - 5092
  • [25] Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy
    Liang, Hanzhi
    Du, Jintong
    Elhassan, Reham M.
    Hou, Xuben
    Fang, Hao
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (01) : 61 - 76
  • [26] Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy
    Roberts, Patrick J.
    Bisi, John E.
    Strum, Jay C.
    Combest, Austin J.
    Darr, David B.
    Usary, Jerry E.
    Zamboni, William C.
    Wong, Kwok-Kin
    Perou, Charles M.
    Sharpless, Norman E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (06): : 476 - 487
  • [27] Anti-cancer therapy with cyclin-dependent kinase inhibitors: impact and challenges
    Reinius, Marika A. V.
    Smyth, Elizabeth
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2021, 23
  • [28] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Gitig, DM
    Koff, A
    MOLECULAR BIOTECHNOLOGY, 2001, 19 (02) : 179 - 188
  • [29] Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors
    Diana M. Gitig
    Andrew Koff
    Molecular Biotechnology, 2001, 19 : 179 - 188
  • [30] CYCLIN-DEPENDENT KINASE REGULATION
    LEES, E
    CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (06) : 773 - 780